We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Hemogenyx Pharmaceuticals Plc | LSE:HEMO | London | Ordinary Share | GB00BYX3WZ24 | ORD GBP0.01 |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
-0.083 | -5.78% | 1.352 | 1.42 | 1.598 | 1.352 | 1.352 | 1.35 | 58,249 | 08:15:00 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
Finance Services | 0 | -6.69M | -0.0050 | -2.86 | 19.26M |
Date | Subject | Author | Discuss |
---|---|---|---|
23/3/2024 10:16 | With the on going viruses/pandemics the pharmaceutical industry are gearing up in preparation " pre-loaded syringes " The pharmaceutical Bio-Defense security Are imposing Sanctions against China`s Manufacture's / providers with the recent request from the F.D.A for Hospitals to Relinquish the use of syringes from China. Will Hemogenyx Have a Alternative Source of supply for the Splicing of the Lentivirus is a Question that should be addressed ? | dreamtwister | |
23/3/2024 06:46 | Pfizer are looking to repair the damage caused to their share price by finding a Cancer Drug that Demonstrably works. Pfizer have the Money and the will to buy anything they want and it would appear HEMO are an ideal fit. Interesting days ahead for all holders. This plague of Cancer is gathering some pace, and affecting all ages, from very young and fit to very Old and infirm. | steveberyl | |
22/3/2024 14:30 | The Company intends to progress HEMO-CAR-T to phase 1 clinical trials commencing shortly. Could even be news on this as early as next week? | apotheki | |
21/3/2024 17:25 | End of tax year selling in small caps really doesn't help including of course here but the shares will no doubt be on the way back up again shortly. Must say I can not wait to see the end of the tax year pass on by. On that note I am looking forward to much better small cap markets post the Easter holidays. | apotheki | |
20/3/2024 17:44 | Terrible to advise a distressed investor to buy a stock at 1.95 when you have no qualifications to give advice. | countbasie1 | |
20/3/2024 15:43 | Any update Apokethi? Still holding? | premium beeks | |
20/3/2024 14:22 | US government moves to block Chinese biotech's’ operations. Chinese biotech companies operating in the US are facing legislative efforts to limit their ability to work with US government agencies or companies that hold (or wish to hold) government contracts. If i recall the Hemogenyx Cbr platform " Decease X " is presently accommodated under strict security in the U.S.A, Biodefense Laboratory also the ingredients/formular for Car-T Cd19FLT33 is spliced in China. it seems very Odd of the Fda to lift the clinical hold knowing of the Wuxi/Hemogenyx connection. | dreamtwister | |
20/3/2024 13:30 | Placees caught with their pants down and piling out. | john henry | |
20/3/2024 13:28 | On the horizon of the new financial year will give Dr Sandler a 20% financial First Aid placing + He can also execute his awarded share options enabling the clinical trials to proceed. | dreamtwister | |
20/3/2024 13:21 | The share price is getting weaker | jibba jabber | |
20/3/2024 13:01 | The news flow is getting stronger ! Cell therapy without cells': Capstan raises $175M to test in vivo CAR-T 175m was oversubscribed by Six large industry pharmaceutical companies. The goal is a cheaper-to-produce, less complex and more accessible cell therapy. | dreamtwister | |
19/3/2024 11:31 | the science is evolving towards eradicating this dreadful decease ! | dreamtwister | |
19/3/2024 09:46 | Meanwhile a 20% drop from the placing. Not great.Apokethi - you should head over to SHOE, I'm taking a bath in that position currently. | premium beeks | |
19/3/2024 09:24 | Is HEMO the next Currys?No, because no one will ever make an offer for them! | premium beeks | |
19/3/2024 08:55 | Only 3 days to the next CURRYS | apotheki | |
19/3/2024 08:46 | Exciting for Advfn yes. More spamming means more clicks and more revenue.The share price currently going down with cash burn. At what point do they come back to market for more?Will it be at 5p? Even on a price spike the boss was too thick to raise funds - preferring to wait for the ultimate dilution at 2p.But hey, it's your money.PS - you say you are talking to holder however from your post you weren't one yourself. Kindly bring silence to the discussion in future. | premium beeks | |
19/3/2024 08:41 | Good moaning to all actual shareholders. Bought sub 2p didn't quite get the spike at over 6p but still managed the high 5p's Back in now sub 2p prior to the commencement of the clinical trails - exciting times! | apotheki | |
15/3/2024 20:27 | As long as you don't collapse and fall into a korma. | countbasie1 | |
15/3/2024 17:45 | CHINESE perhaps? | apotheki | |
15/3/2024 17:00 | Friday the night of the CURRYS | apotheki | |
15/3/2024 16:00 | When can we expect your investment flyer on this Chairman?I can alert the necessary threads of an incoming useless ramp. | premium beeks | |
15/3/2024 14:30 | The Company intends to progress HEMO-CAR-T to phase 1 clinical trials commencing shortly. Could even be news on this as early as next week? | apotheki |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions